Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|November 15, 2021

Strategies for recruiting female urologists to your practice

At the 2021 LUGPA Annual Meeting Jennifer Miles-Thomas, MD, FPMRS, president, Urology Of Virginia, participated in a panel discussion titled, “Strategies to Recruit and Retain Female Urologists in your Practice.” In this video, Miles-Thomas explains why urology practices need to have female urologists and approaches for recruiting them.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix

ByBenjamin H. Lowentritt, MD, FACS

June 11th 2026

Pearls & Perspectives: The Evolving Landscape of Female Pelvic Health, With Annah J. Vollstedt, MD

ByAmy M. Pearlman, MD,Annah J. Vollstedt MD

June 9th 2026

Study suggests potential diuretic effect with nadofaragene firadenovec

ByAbigail Keller, MD

June 8th 2026

Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026

ByClint D. Bahler, MD

June 5th 2026

RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC

ByBenjamin P. Saylor, Strategic Content Lead

June 5th 2026

Latest CME

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Trending on Urology Times

Clinical Application of MMAI Score in Patients with Prostate Cancer

FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC

FDA approves adjuvant belzutifan with pembrolizumab for ccRCC

Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix

Jonathan Harper, MD, shares PUSH trial findings on hydration and stone recurrence